pharmaceutical - Latest News, Analysis, Opinion

In India, the Danish drugmaker Novo Nordisk is the market leader and presently meets over 60 per cent of the country’s insulin supply. Speaking to BW Businessworld in an exclusive interaction, John C. Dawber, CVP and MD, Global Business Services talks about the company’s GLP1 growth story, the market of obesity drugs and their safety profile, building capacities and the company's future ambitions in India

Exclusive: Existing Legal Framework Needs To Be More Robust For Healthcare's Carbon Footprint

Experts believe with access to health rising post-pandemic in India, the carbon footprint is also slated to rise simultaneously. The report by HWH also affirms this by showing a strong correlation between a nation’s health spending and its carbon footprint. India at present is witnessing a huge capacity build in the healthcare sector with the healthcare providers expanding their bed capacities on account of increasing bed occupancies in the hospitals

Exploring India's Increasing Role in Clinical Trials, Addressing Key Concerns

Bhupendra Paintola

The key drivers for clinical trials in India include access to treatment-naïve patients (especially in Tier 2 and 3 cities), a high disease burden, lower cost, and good medical infrastructure (even in Tier 2/3 cities)

India-Russia Aim To Reach $50 Bn In Bilateral Trade In 2023: Embassy In Moscow

The two countries have the potential to develop in sectors like pharmaceuticals, chemicals and agriculture, said the Head of the Economic and Commercial Department of the Embassy of India in Moscow

Zydus Gets Nil Observations On USFDA Inspection, Receives Nod For Two Drugs

On Tuesday, Zydus Lifesciences in an exchange filing revealed that the group’s injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad, underwent USFDA inspection from 05 June to 13 June 2023 with the cGMP inspection concluded with nil observations

Biden Govt Sets Penalties On 43 Drugs Over Price Hikes

The Biden administration on Friday announced it would impose inflation penalties on 43 drugs for the third quarter of 2023, having fined 27 earlier this year, in a move it said would lower costs for older Americans by as much as USD 449 per dose.

Biocon Investing Heavily In Peptides, Potent Oncology APIs: MD & CEO, Siddharth Mittal

Biocon’s MD and CEO, Siddharth Mittal in a post-annual results interaction with BW Healthcare World stated that, “As we move forward, we see a huge potential in peptides. It is a growing segment where the big shift is being seen with companies like Novo Nordisk or Eli Lilly moving their focus from insulins to GLP1 drugs and what used to be USD 20-30 billion insulin market is now actually projected to be over USD 100 billion GLP1 market"

Mankind Pharma Q4: Profits Rise By 52% YoY To Rs 294 Cr

Mankind Pharma, the Indian pharma major announced its financial results for the fourth quarter and full year ended March 31, 2023. The company's Profit After Tax (PAT) in the fourth quarter surged by 52 per cent year on year (YoY) to Rs 294 crore against Rs 193 crore recorded in the corresponding quarter last year

Torrent Pharma Posts Net Profit Of Rs 287 Cr, Sales Up By 17% In Q4FY23

Ahmedabad-based Indian pharmaceutical major Torrent Pharmaceutical on Tuesday posted its financials for the fourth quarter and full year ending March 31, 2023. The company posted a net profit of Rs 287 crores in the January-March quarter against a net loss of Rs 188 crores recorded in Q4 last year

Biocon's Net Profits Soar In Q4FY23 By 31% YoY, Revenues Up By 58.6%

Bangalore-based pharmaceutical company Biocon on Tuesday announced its consolidated financial results for the fourth quarter that ended 31st March 2023, the company registered a 58.6 per cent rise in its consolidated revenues from operations year on year. The company's consolidated revenue for the March quarter stood at Rs 3,928 crores against Rs 2,476 crores in the same quarter last year

Centre Makes Testing Mandatory For Exporting Cough Syrups After Overseas Deaths

India will make tests mandatory for cough syrups before they are exported, a government notice showed on Tuesday, after Indian-made cough syrups were linked to the deaths of dozens of children in Gambia and Uzbekistan

Divi's Labs PAT Slumps By 64.2% In Q4FY23

Divi's Laboratories on Saturday announced its earnings for the fourth quarter and full year FY23. The company posted a drop in its net profits by 64.2 per cent year on year (YoY) in the March quarter to Rs 320 crores down from 894 crores in the same quarter of the previous year

Glenmark Pharma Registers Lower Q4 Profit On Account Of One-Off Expense

Consolidated profit before exceptional items and tax fell to Rs 309 crores for the three months ended March 31, from Rs 352 crores billion a year earlier, the cetirizine maker said in a stock exchange filing

India Considering A Policy Change In Pharma After Cough Syrup Deaths